Cargando…
Production of recombinant lumpy skin disease virus A27L and L1R proteins for application in diagnostics and vaccine development
Vaccination using live attenuated vaccines (LAVs) is considered the most effective method for control of lumpy skin disease (LSD). However, this method is limited by safety concerns, with reports of adverse reactions following vaccination. This study evaluates A27L and L1R which are essential protei...
Autores principales: | Ntombela, Nomfundo, Matsiela, Matome, Zuma, Sbahle, Hiralal, Suhavna, Naicker, Leeann, Mokoena, Nobalanda, Khoza, Thandeka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509699/ https://www.ncbi.nlm.nih.gov/pubmed/37736535 http://dx.doi.org/10.1016/j.jvacx.2023.100384 |
Ejemplares similares
-
Improved safety profile of inactivated Neethling strain of the Lumpy Skin Disease Vaccine
por: Matsiela, Matome Selina, et al.
Publicado: (2022) -
Safety and immunogenicity of inactivated Rift Valley Fever Smithburn viral vaccine in sheep
por: Matsiela, Matome Selina, et al.
Publicado: (2023) -
Protection of Cattle Elicited Using a Bivalent Lumpy Skin Disease Virus-Vectored Recombinant Rift Valley Fever Vaccine
por: Wallace, David B., et al.
Publicado: (2020) -
Lumpy skin disease in Kazakhstan
por: Orynbayev, Mukhit B., et al.
Publicado: (2021) -
Application of a real-time cell analysis system in the process development and quantification of Rift Valley fever virus clone 13
por: Moetlhoa, Boitumelo, et al.
Publicado: (2020)